<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>47(3)</volume><submitter>Fikkert V</submitter><journal>Antimicrobial agents and chemotherapy</journal><pagination>1177-1177</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC149344</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>env Chimeric Virus Technology for Evaluating Human Immunodeficiency Virus Susceptibility to Entry Inhibitors</pubmed_title><pmcid>PMC149344</pmcid><pubmed_authors>Van Laethem K</pubmed_authors><pubmed_authors>Cherepanov P</pubmed_authors><pubmed_authors>Vandamme A</pubmed_authors><pubmed_authors>Van Remoortel B</pubmed_authors><pubmed_authors>Clercq E</pubmed_authors><pubmed_authors>Debyser Z</pubmed_authors><pubmed_authors>Witvrouw M</pubmed_authors><pubmed_authors>Pannecouque C</pubmed_authors><pubmed_authors>Fikkert V</pubmed_authors><pubmed_authors>Hantson A</pubmed_authors></additional><is_claimable>false</is_claimable><name>env Chimeric Virus Technology for Evaluating Human Immunodeficiency Virus Susceptibility to Entry Inhibitors</name><description/><dates><release>2003-01-01T00:00:00Z</release><publication>2003 Mar</publication><modification>2025-04-04T07:10:44.909Z</modification><creation>2025-02-19T03:17:35.045Z</creation></dates><accession>S-EPMC149344</accession><cross_references/></HashMap>